Tesamorelin is a stabilized synthetic analogue of growth hormone-releasing hormone (GHRH), designed to stimulate endogenous growth hormone production through pituitary activation. In research settings, Tesamorelin has been studied for its impact on reducing visceral adiposity, improving IGF-1 levels, and modulating lipid metabolism.
Its stability and resistance to enzymatic degradation make it a reliable compound for investigations into metabolic regulation, muscle preservation, and hormone-related signaling pathways.
This compound is offered as a lyophilized powder in sterile, unlabeled glass vials to ensure purity and versatility in research settings. Our 10-vial research kits are produced under stringent quality control protocols and are independently batch-tested for identity and purity.
Each vial is intended for in vitro use only. Not for human consumption. Not for therapeutic or diagnostic purposes.
